CD8A and neoplasm: NF‐κB‐inducible kinase promotes CD8+ T cell metabolism and activation through metabolic reprogramming toward aerobic glycolysis, thereby enhancing the therapeutic efficacy of T cell adoptive therapy (tumor size reduction).189